Piromelatine for Mild Alzheimer's Disease (ReCOGNITION)
Language
Undefined
Purpose: To test the safety and efficacy of the experimental drug piromelatine in people with mild Alzheimer's dementia. (Source: Alzheimers Clinical Trials)
Source: Alzheimers Clinical Trials - December 24, 2015 Category: Geriatrics Authors: chirschman Source Type: clinical trials
SUVN-502 with Donepezil and Memantine for Moderate Alzheimer's Disease
Language
Undefined
Purpose: To test the experimental drug SUVN-502 as a treatment for moderate Alzheimer's disease in people taking donepezil and memantine. (Source: Alzheimers Clinical Trials)
Source: Alzheimers Clinical Trials - November 20, 2015 Category: Geriatrics Authors: chirschman Source Type: clinical trials
Trial of Oxaloacetate in Alzheimer's Disease (TOAD)
Language
Undefined
Purpose: To determine if oxaloacetate is safe and tolerable in people with Alzheimer's disease. (Source: Alzheimers Clinical Trials)
Source: Alzheimers Clinical Trials - November 20, 2015 Category: Geriatrics Authors: chirschman Source Type: clinical trials
RVT-101 for Mild to Moderate Alzheimer's Disease with Donepezil (MINDSET)
Language
Undefined
Purpose: To study the experimental drug RVT-101 as an add-on treatment for Alzheimer's disease. (Source: Alzheimers Clinical Trials)
Source: Alzheimers Clinical Trials - November 20, 2015 Category: Geriatrics Authors: chirschman Source Type: clinical trials
18F-AV-1451 Autopsy Study
Language
Undefined
Purpose: To test the relationship between tau pathology and the brain imaging agent 18F-AV-1451 in people near the end of life. (Source: Alzheimers Clinical Trials)
Source: Alzheimers Clinical Trials - November 20, 2015 Category: Geriatrics Authors: chirschman Source Type: clinical trials
Grape Seed Extract for Alzheimer's Disease
Language
Undefined
Purpose: To establish the safety and pharmacokinetics of grape seed extract and to test its cognitive effects in people with Alzheimer's disease. (Source: Alzheimers Clinical Trials)
Source: Alzheimers Clinical Trials - November 20, 2015 Category: Geriatrics Authors: chirschman Source Type: clinical trials
BI 409306 for Alzheimers Disease or Schizophrenia
Language
Undefined
Purpose: To test the experimental drug BI 409306 in people with Alzheimer's disease or schizophrenia and in healthy volunteers. (Source: Alzheimers Clinical Trials)
Source: Alzheimers Clinical Trials - October 19, 2015 Category: Geriatrics Authors: chirschman Source Type: clinical trials
Piano Training and Cognitive Performance in Older Adults
Language
Undefined
Purpose: To compare the impact on cogition and psychosocial well-being of piano training, compared with computer training and no training, in older adults. (Source: Alzheimers Clinical Trials)
Source: Alzheimers Clinical Trials - October 19, 2015 Category: Geriatrics Authors: chirschman Source Type: clinical trials
T3D-959 for Mild to Moderate Alzheimer's Disease
Language
Undefined
Purpose: To assess the effects of the experimental drug T3D-959 in people with mild to moderate Alzheimer's disease. (Source: Alzheimers Clinical Trials)
Source: Alzheimers Clinical Trials - October 19, 2015 Category: Geriatrics Authors: chirschman Source Type: clinical trials
BI 409306 for Cognitive Impairment Due to Alzheimer's Disease
Language
Undefined
Purpose: To test the experimental drug BI 409306 in people with cognitive impairment due to Alzheimer's disease. (Source: Alzheimers Clinical Trials)
Source: Alzheimers Clinical Trials - October 19, 2015 Category: Geriatrics Authors: chirschman Source Type: clinical trials
EMERGE: Aducanumab (BIIB037) for Early Alzheimer's Disease
Language
Undefined
Purpose: To evaluate treatment of early Alzheimer's disease with the experimental drug aducanumab (BIIB037). (Source: Alzheimers Clinical Trials)
Source: Alzheimers Clinical Trials - October 19, 2015 Category: Geriatrics Authors: chirschman Source Type: clinical trials
STARBEAM: Lu AE58054 in People with Mild to Moderate Alzheimer's Disease Taking Donepezil
Language
Undefined
Purpose: To test Lu AE58054 as an add-on therapy to donepezil in people with mild to moderate Alzheimer's disease. (Source: Alzheimers Clinical Trials)
Source: Alzheimers Clinical Trials - September 18, 2015 Category: Geriatrics Authors: chirschman Source Type: clinical trials
STARBRIGHT: Lu AE58054 in People with Mild to Moderate Alzheimer's Disease Taking an Acetylcholinesterase Inhibitor
Language
Undefined
Purpose: To test Lu AE58054 as an add-on therapy to acetylcholinesterase inhibitors in people with mild to moderate Alzheimer's disease. (Source: Alzheimers Clinical Trials)
Source: Alzheimers Clinical Trials - September 18, 2015 Category: Geriatrics Authors: chirschman Source Type: clinical trials
Dietary Treatments for Cognitive Impairment
Language
Undefined
Purpose: To study the effect on cognition of a modified Atkins diet in older adults with mild cognitive impairment or early Alzheimer's disease. (Source: Alzheimers Clinical Trials)
Source: Alzheimers Clinical Trials - September 18, 2015 Category: Geriatrics Authors: chirschman Source Type: clinical trials
Intranasal Glulisine for Amnestic MCI or Mild Alzheimer's Disease
Language
Undefined
Purpose: To evaluate the use of intranasal glulisine in people with amnestic mild cognitive impairment or mild Alzheimer's disease. (Source: Alzheimers Clinical Trials)
Source: Alzheimers Clinical Trials - September 18, 2015 Category: Geriatrics Authors: chirschman Source Type: clinical trials
